Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0800
    +0.0007 (+0.06%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2637
    +0.0015 (+0.11%)
     
  • USD/JPY

    151.2160
    -0.1560 (-0.10%)
     
  • Bitcoin USD

    70,443.55
    -447.02 (-0.63%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

Why Gilead Sciences (GILD) Could Beat Earnings Estimates Again

Looking for a stock that might be in a good position to beat earnings at its next report? Consider Gilead Sciences Inc. (GILD), a firm in the medical industry, which could be a great candidate for another beat.

This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, GILD has beaten estimates by at least 40% in both cases, suggesting it has a nice short-term history of crushing expectations.

Earnings in Focus

Two quarters ago, GILD expected to earn 75 cents per share, while it actually produced earnings of $1.44 per share, a beat of 92%. Meanwhile, for the most recent quarter, the company looked to deliver earnings of $1.61 per share, when it actually saw earnings of $2.32 per share instead, representing a 44.1% positive surprise.

Thanks in part to this history, recent estimates have been moving higher for Gilead Sciences. In fact, the Earnings ESP for GILD is positive, which is a great sign of a coming beat.

After all, the Zacks Earnings ESP compares the most accurate estimate to the broad consensus, looking to find stocks that have seen big revisions as of late, suggesting that analysts have recently become more bullish on the company’s earnings prospects. This is the case for GILD, as the firm currently has a Zacks Earnings ESP of 8.54%, so another beat could be around the corner.

This is particularly true when you consider that GILD has a great Zacks Rank #1 (Strong Buy) which can be a harbinger of outperformance and a signal for a strong earnings profile. And when you add this solid Zacks Rank to a positive Earnings ESP, a positive earnings surprise happens nearly 70% of the time, so it seems pretty likely that GILD could see another beat at its next report, especially if recent trends are any guide.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>




GILEAD SCIENCES INC (GILD): Free Stock Analysis Report


Zacks Investment Research

Advertisement